|
Market Cap (1-Jul) $205,017,904 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (19-Jun) 40,298 (0.02%) (504th) |
|
52w High $1.97 |
52w Low $0.92 |
P/E - |
EPS -0.05 |
RAC released this announcement to the ASX on 1 February 2023, 9:26. The announcement is marked as price sensitive, and is 2 page(s) in length and 126.08kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.000% short sold according to ASIC data. It was ranked the 629th most shorted stock on the ASX. It is now ranked as the 504th most shorted stock on the ASX with 0.023% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Race Receives Cardioprotection Ethics Trial Approval | 1 February 2023, 9:26 |
| Appendix 3X - Damian Clarke-Bruce | 1 February 2023, 8:50 |
| Quarterly Activity Report & Appendix 4C | 31 January 2023, 11:07 |
| Letter to Shareholders, Notice of Meeting & Proxy Form | 19 January 2023, 16:37 |
You must be logged in to post a reply.
Race Oncology 